Pereira Neto Bárbara, Pais Cunha Ines, Leite-Almeida Ana Laura, Ferreira Sofia, Coelho Janine, Lago Rita, Pereira Josué, Gil-da-Costa Maria João, Almeida Paulo, Castro-Correia Cintia
Pediatrics, Centro Hospitalar Universitário de São João, Porto, PRT.
Pediatric Endocrinology and Diabetology Unit, Centro Hospitalar Universitário de São João, Porto, PRT.
Cureus. 2024 Jan 20;16(1):e52621. doi: 10.7759/cureus.52621. eCollection 2024 Jan.
Craniopharyngiomas (CP) are tumors in the sellar region that, despite a high survival rate, are associated with significant morbidity, including hypothalamic, hormonal, and visual dysfunction. This study aimed to assess the quality of life (QoL) in pediatric patients with CP and to evaluate its relationship with various factors, with a focus on the impact of endocrine dysfunction.
In this observational cross-sectional study, patients with CP aged between 0 and 18 years, currently followed up in a tertiary hospital by a multidisciplinary team, were included. QoL was assessed using the validated PEDS-QL4.0 questionnaire, which was administered to parents. This tool estimates Global QoL (QoL-G), further divided into Physical (QoL-P) and Psychosocial (QoL-PS) dimensions, including Emotional (QoL-Em), Social (QoL-S), and School (QoL-Sc) aspects. In Portugal, the estimated average QoL-G is 79.8, QoL-P is 83.5, and QoL-PS is 78.2. Variables studied included gender, current and diagnostic age, follow-up time, presence of hydrocephalus, hypothalamic involvement, type of resection (total or subtotal), radiotherapy, visual impairment, hormonal deficits, and therapy.
The study included 11 patients with a median age of 15.2 years (interquartile ratio (IQR), 9.7-17.9 years) and a mean age at diagnosis of 9.3±4.1 years. Of these patients, 54.5% were male, and 36.4% were obese. Subtotal resection was performed in 72.7% of cases. Hydrocephalus was present in 54.5% of the patients, hypothalamic involvement in 63.7%, radiotherapy was received by 81.8%, and visual impairment was noted in 54.5%. All patients presented with at least one hormonal deficit. The average QoL-G was 69.9±22.5, with QoL-P at 66.9±30.0 and QoL-PS at 70.9±21.4. A worse QoL-S was associated with female gender (p=0.030) and subtotal resection (p=0.048). Worse QoL-G, QoL-P, QoL-Em, and QoL-PS were linked to hypothalamic involvement (p values 0.008, 0.025, 0.015, and 0.009, respectively). Irradiated patients had worse QoL-G (p=0.006). Treatment with sexual hormones enhanced QoL-Global (p=0.035) and QoL-Emotional (p=0.020), while treatment for adrenal insufficiency and diabetes insipidus improved QoL-Emotional (p=0.021 and p=0.013). No significant associations with visual deficit or obesity were found.
Pediatric patients with CP appear to have poorer QoL-G, QoL-P, and QoL-PS compared to the healthy Portuguese population. However, the small sample size limits statistically significant associations with many of these variables. Predictors of worse QoL include female gender, hypothalamic involvement, subtotal resection, and radiotherapy. The results may be biased due to the small sample size, questionnaire administration to parents, and possible inadequacy of the questionnaire for the studied population. There is a need for a more suitable tool to enable a more precise assessment of QoL in these patients.
颅咽管瘤(CP)是鞍区肿瘤,尽管生存率较高,但与显著的发病率相关,包括下丘脑、激素和视觉功能障碍。本研究旨在评估小儿颅咽管瘤患者的生活质量(QoL),并评估其与各种因素的关系,重点关注内分泌功能障碍的影响。
在这项观察性横断面研究中,纳入了年龄在0至18岁之间、目前在一家三级医院由多学科团队进行随访的颅咽管瘤患者。使用经过验证的PEDS-QL4.0问卷对父母进行生活质量评估。该工具评估总体生活质量(QoL-G),进一步分为身体(QoL-P)和心理社会(QoL-PS)维度,包括情感(QoL-Em)、社会(QoL-S)和学校(QoL-Sc)方面。在葡萄牙,估计的平均总体生活质量为79.8,身体生活质量为83.5,心理社会生活质量为78.2。研究的变量包括性别、当前年龄和诊断年龄、随访时间、脑积水的存在、下丘脑受累情况、切除类型(全切或次全切)、放疗、视力损害、激素缺乏和治疗情况。
该研究纳入了11名患者,中位年龄为15.2岁(四分位间距(IQR),9.7 - 17.9岁),诊断时的平均年龄为9.3±4.1岁。其中,54.5%为男性,36.4%为肥胖患者。72.7%的病例进行了次全切。54.5%的患者存在脑积水,63.7%的患者下丘脑受累,81.8%的患者接受了放疗,54.5%的患者存在视力损害。所有患者均至少存在一种激素缺乏。平均总体生活质量为69.9±22.5,身体生活质量为66.9±30.0,心理社会生活质量为70.9±21.4。较差的社会生活质量与女性性别(p = 0.030)和次全切(p = 0.048)相关。较差的总体生活质量、身体生活质量以及情感和心理社会生活质量与下丘脑受累有关(p值分别为0.008、0.025、0.015和0.009)。接受放疗的患者总体生活质量较差(p = 0.006)。性激素治疗可提高总体生活质量(p =